199 related articles for article (PubMed ID: 19151898)
1. Genetic etiologies for phenotypic diversity in sickle cell anemia.
Steinberg MH
ScientificWorldJournal; 2009 Jan; 9():46-67. PubMed ID: 19151898
[TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of sickle cell disease.
Steinberg MH; Sebastiani P
Am J Hematol; 2012 Aug; 87(8):795-803. PubMed ID: 22641398
[TBL] [Abstract][Full Text] [Related]
3. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.
Fertrin KY; Costa FF
Expert Rev Hematol; 2010 Aug; 3(4):443-58. PubMed ID: 21083035
[TBL] [Abstract][Full Text] [Related]
4. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
[TBL] [Abstract][Full Text] [Related]
5. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.
Habara A; Steinberg MH
Exp Biol Med (Maywood); 2016 Apr; 241(7):689-96. PubMed ID: 26936084
[TBL] [Abstract][Full Text] [Related]
6. Predicting clinical severity in sickle cell anaemia.
Steinberg MH
Br J Haematol; 2005 May; 129(4):465-81. PubMed ID: 15877729
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the phenotypic diversity of sickle cell anemia.
Steinberg MH
Hemoglobin; 1996 Feb; 20(1):1-19. PubMed ID: 8745428
[TBL] [Abstract][Full Text] [Related]
8. HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.
Joly P; Bonello-Palot N; Badens C; Pissard S; Chamouine A; Bernaudin F; Bertrand Y; Connes P; Renoux C
Clin Hemorheol Microcirc; 2021; 77(3):267-272. PubMed ID: 33216016
[TBL] [Abstract][Full Text] [Related]
9. Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
de Azevedo LA; Bonazzoni J; Wagner SC; Farias MG; Bittar CM; Daudt L; de Castro SM
Mol Diagn Ther; 2017 Aug; 21(4):437-442. PubMed ID: 28567595
[TBL] [Abstract][Full Text] [Related]
10. Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations.
Sebastiani P; Wang L; Nolan VG; Melista E; Ma Q; Baldwin CT; Steinberg MH
Am J Hematol; 2008 Mar; 83(3):189-95. PubMed ID: 17918249
[TBL] [Abstract][Full Text] [Related]
11. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
[TBL] [Abstract][Full Text] [Related]
12. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
[TBL] [Abstract][Full Text] [Related]
13. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
15. Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.
Nolan VG; Adewoye A; Baldwin C; Wang L; Ma Q; Wyszynski DF; Farrell JJ; Sebastiani P; Farrer LA; Steinberg MH
Br J Haematol; 2006 Jun; 133(5):570-8. PubMed ID: 16681647
[TBL] [Abstract][Full Text] [Related]
16. Modifier genes and sickle cell anemia.
Steinberg MH; Adewoye AH
Curr Opin Hematol; 2006 May; 13(3):131-6. PubMed ID: 16567954
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia.
Wyszynski DF; Baldwin CT; Cleves MA; Amirault Y; Nolan VG; Farrell JJ; Bisbee A; Kutlar A; Farrer LA; Steinberg MH
Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):23-33. PubMed ID: 15040424
[TBL] [Abstract][Full Text] [Related]
18. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
19. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.
Ma Q; Wyszynski DF; Farrell JJ; Kutlar A; Farrer LA; Baldwin CT; Steinberg MH
Pharmacogenomics J; 2007 Dec; 7(6):386-94. PubMed ID: 17299377
[TBL] [Abstract][Full Text] [Related]
20. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
